HC Wainwright Affirms Buy Rating on Lineage Cell Therapeutics Inc. (LCTX) amid Type 1 Diabetes Push

Lineage Cell Therapeutics Inc. (NYSE:LCTX) is one of the best performing penny stocks to buy now. On September 9, HC Wainwright reiterated a ‘Buy’ rating on the stock and a $9 price target, buoyed by ...

GHO Capital Sells VISUfarma to Lupin

Global Healthcare Opportunities, or GHO Capital Partners LLP (“GHO”), the European specialist investor in global healthcare, ...